Literature DB >> 18277119

Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome.

Yahya Buyukasik1, Umit Akman, Naciye S Buyukasik, Hakan Goker, Alparslan Kilicarslan, Ali I Shorbagi, Gulsen Hascelik, Ibrahim C Haznedaroglu.   

Abstract

BACKGROUND: The genetic polymorphism responsible from Gilbert's syndrome is not sufficient for the clinical phenotype to occur in many persons. Additional factors are believed to contribute in pathogenesis. Red cell mass may be such a factor.
METHODS: We have retrospectively evaluated computer records of all liver function tests assayed between January 2005 and February 2006. The database was screened to find cases with unconjugated hyperbilirubinemia and normal liver enzymes and blood count values on simultaneous assays. The control group for comparison of surrogate markers of total red cell mass comprised of age- and gender-matched persons who had laboratory tests with completely normal results on the same day with the hyperbilirubinemic cases. Gilbert's syndrome cases were found with medical record assessment, and these cases and their control subjects were more strictly assessed. Three different control groups were established for Gilbert's syndrome cases, one of them including healthy blood donors and personnel.
RESULTS: In 48,516 otherwise normal laboratory test results, we have found that 491 male subjects and 323 female subjects with unconjugated hyperbilirubinemia had higher hemoglobin, hematocrit, and red blood cell values compared with age- and gender-matched control subjects (P < 0.001 for all comparisons). Twenty-six males who had been followed for Gilbert's syndrome also showed higher hemoglobin, hematocrit and red cell count values in comparison to all control groups. Mean red cell volume value did not differ between the hyperbilirubinemic persons and control groups.
CONCLUSIONS: Relatively increased red cell mass probably plays a role in the pathogenesis of Gilbert's syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18277119     DOI: 10.1097/MAJ.0b013e318142be0d

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis.

Authors:  Maria do Sameiro-Faria; Michaela Kohlova; Sandra Ribeiro; Petronila Rocha-Pereira; Laetitia Teixeira; Henrique Nascimento; Flávio Reis; Vasco Miranda; Elsa Bronze-da-Rocha; Alexandre Quintanilha; Luís Belo; Elísio Costa; Alice Santos-Silva
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

2.  Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant.

Authors:  Dan Zhang; Bo Zhu; Wei Zhang; Wei Wang; Dan Guo; Ligang Yang; Lu Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

3.  Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome.

Authors:  Ling-Ling Kang; Yong-Jian Ma; Hou-De Zhang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.